The second-look operation improves survival in suboptimally debulked stage III ovarian cancer patients

International Journal of Gynecological Cancer

Volumn 15, Issue 1, 2005, Pages 19-25

  Rahaman, Jamal ^a   Dottino, P ^a   Jennings, T S ^a   Holland, J ^a   Cohen, C J ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Ovarian cancer survival; Second look surgery; Suboptimal cytoreduction

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL; PLATINUM DERIVATIVE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SECOND LOOK SURGERY; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; COHORT STUDIES; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PLATINUM COMPOUNDS; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 13244279459     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1048-891X.2005.15003.x     Document Type: Article

References (35)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Wangensteen OH, Lewis FJ, Tongen LA. The 'second-look' in cancer surgery. A patient with colic cancer and involved lymph nodes negative on the 'sixth look'. Lancet 1951;71:303-7.
3. Sanatoro BT, Griffen WO, Wangensteen OH. The second-look procedure in the management of ovarian malignancies and pseudomyxoma peritonei. Surgery 1961;50:354-8.
4. Rutledge F, Burns BC. Chemotherapy for advanced ovarian cancer. Am J Obstet Gynecol 1966;96:761-72.
5. Wallach RC, Blinick G. The second look operation for carcinoma of the ovary. Surg Gynecol Obstet 1970;131:1085-9.
6. Smith JP, Delgado G, Rutledge F. Second-look operation in ovarian carcinoma: postchemotherapy. Cancer 1976;38:1438-42.
7. Reimer RR, Hoover R, Fraumeni JF Jr, Young RC. Acute leukemia after alkylating-agent therapy of ovarian cancer. N Engl J Med 1977;297:177-81.
8. Einhorn N. Acute leukemia after chemotherapy (melphalan). Cancer 1978;41:444-7.
9. Hoskins WJ, Rubin SC, Dulaney E et al. Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma. Gynecol Oncol 1989;34:365-71.
10. Segna RA, Dottino PR, Mandeli JP, Konsker K, Cohen CJ. Secondary cytoreduction for ovarian cancer following cisplatin therapy. J Clin Oncol 1993;11:434-9.
11. Eisenkop SM, Friedman RL, Wang HJ. Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study. Cancer 1995;76:1606-14.
12. Bristow RE, Lagasse LD, Karlan BY. Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Patient selection and review of the literature. Cancer 1996;78:2049-62.
13. Podratz KC, Cliby WA. Second-look surgery in the management of epithelial ovarian carcinoma. Gynecol Oncol 1994;55:S128-33.
14. Copeland LJ, Vaccarello L, Lewandowski GS. Second-look laparotomy in epithelial ovarian cancer. Obstet Gynecol Clin North Am 1994;21:155-66.
15. Nicklin JL, Copeland LJ, Luesley D, Kehoe S. Second look surgery. In: Gershenson DM, McGuire WP, eds. Ovarian Cancer: Controversies in Management. New York: Churchill Livingstone, 1998, 85-100.
16. Creasman WT. Second-look laparotomy in ovarian cancer. Gynecol Oncol 1994;55:S122-7.
17. Barter JF, Barnes WA. Second look laparotomy. In: Rubin SC, Sutton GP, eds. Ovarian Cancer. New York: McGraw-Hill, 1993, 269-300.
18. Cohen CJ, Bruckner HW, Goldberg JD, Holland JF. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery) - the Mount Sinai experience. Clin Obstet Gynaecol 1983;10:307-24.
19. Ho AG, Beller U, Speyer JL, Colombo N, Wernz J, Beckman EM. A reassessment of the role of second-look laparotomy in advanced ovarian cancer. J Clin Oncol 1987;5:1316-21.
20. Chambers SK, Chambers JT, Kohorn EI, Lawrence R, Schwartz PE. Evaluation of the role of second-look surgery in ovarian cancer. Obstet Gynecol 1988;72:404-8.
21. Luesley D, Lawton F, Blackledge G et al. Failure of second-look laparotomy to influence survival in epithelial ovarian cancer. Lancet 1988;2:599-603.
22. Creasman WT, Gall S, Bundy BN, Beecham J, Mortel R, Homesley HD. Second-look laparotomy in the patient with minimal residual stage III ovarian cancer (a Gynecologic Oncology Group Study). Gynecol Oncol 1989;35:378-82.
23. Gall S, Bundy B, Beecham J et al. Therapy of stage III (optimal) epithelial carcinoma of the ovary with melphalan or melphalan plus Corynebacterium parvum (a Gynecologic Oncology Group Study). Gynecol Oncol 1986;25:26-36.
24. Cohen CJ, Goldberg JD, Holland JF et al. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation). Am J Obstet Gynecol 1983;145:955-67.
25. Cohen CJ. Surgical considerations in ovarian cancer. Semin Oncol 1985;12:53-6.
26. Rahaman J, Nezhat F, Dottino PR, Jennings TS, Cohen CJ. The impact of second-look laparoscopy compared to standard second-look laparotomy on recurrence and survival in advanced stage ovarian cancer (Abstract). Gynecol Oncol 2001;80:326-7.
27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
28. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer 1966;50:163-70.
29. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
30. A'Hern RP, Gore ME. Impact of doxorubicin on survival in advanced ovarian cancer. J Clin Oncol 1995;13:726-32.
31. Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis.The Ovarian Cancer Meta-Analysis Project. J Clin Oncol 1991;9:1668-74.
32. Friedman RL, Eisenkop SM, Wang HJ. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival. Gynecol Oncol 1997;67:88-94.
33. Nicoletto MO, Tumolo S, Talamini R et al. Surgical second look in ovarian cancer: a randomized study in patients with laparoscopic complete remission - a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group Study. J Clin Oncol 1997;15:994-9.
34. Potter ME, Hatch KD, Soong SJ, Partridge EE, Austin JM Jr, Shingleton HM. Second-look laparotomy and salvage therapy: a research modality only? Gynecol Oncol 1992;44:3-9.
35. Podratz KC, Kinney WK. Second-look operation in ovarian cancer. Cancer 1993;71:1551-8.